Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

GoPro Inc (GPRO) Stock Doesn’t Need Your Money, It Needs a Clue

GoPro Inc (GPRO) has to switch to industrial markets, targeting specific verticals with complete solutions if GoPro stock is to have a future.

Apple Inc. (AAPL) CEO Tim Cook Needs a Hug

Apple (AAPL) CEO Tim Cook just boasted about Apple Watch sales. But the reason has nothing to do with AAPL stock holders.

Count Facebook Inc (FB) Stock Out If You Hate Money

FB stock has been in the spotlight lately, with political pressure against it rising. But Facebook is about connecting people, and as long as the connections are there, they will be used.

What Microsoft Corporation (MSFT) and Tesla Motors Inc (TSLA) Say About Investors

Microsoft (MSFT) is changing the world just as much as Tesla Motors (TSLA) is. But MSFT stock is running because it's doing so with less risk.

Fitbit Inc (FIT) Stock Could Get a Burst of New Life If This Happens

Fitbit stock is down because its current market is exhausted. But if FIT sells to employers who want to control healthcare costs, it could gain new life.